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Abstract 
BACKGROUND: Persistent corneal epithelial defect (PED) is a consequence of many ocular surface disorders. 
Although many therapies have been suggested, the treatment of this disease have faced a lot of difficulties up to 
now. The transplatation of cultivated amniotic epithelial cells sheets is the new promised method for PED. Cord 
lining epithelial cells (CLECs) are epithelial cells of amniotic membrane of umbilical cord, so these cultivated cells 
sheet may be good for treating PED 
AIM: To evaluate the efficacy of the transplantation of cultivated CLECs sheets in treatment of PED and analyze 
some influential factors of this therapy.  
METHODS: A prospective interventional case series with transplantation of tissue-cultured human CLECs in 37 
PED eyes in Vietnam National Institute of Ophthalmology.  
RESULTS: Thirty four of 37 eyes were healed with the cells transplantation and 22 eyes of them healed within a 
week postoperatively. There were normal corneal scars and normal corneal epithelial cell (by impression cytology 
detection) on transplantation site in all 31 successful cases. The other successful eyes were done lamellar 
keratoplasty (respectively in 1 month, 3 months, 6 months and 27 months postoperatively) to investigate the 
histopathology of the CLECs transplant site. The histopathological images showed normal corneal scar and there 
was no appearance of CLECs in transplant site.  
CONCLUSION: tissue-cultured human CLECs transplantation is a quite safe and effective treatment for persistent 
corneal epithelial defect. The CLECs may help the epithelial healing at early stage but do not exist at transplant 
site for a long time. 
 
 
 
 
Introduction 
 
Persistent epithelial defect (PED) of cornea 
occurs when the corneal epithelium fails to regenerate 
steadily over a corneal wound within due course 
(usually less than 2 weeks in normal corneas), 
although the wound has been intensively treated [1]. 
The potential causes of PED are myriad and its 
mechanisms remain unclear, related to multiple 
factors and hard to determine specifically. Therefore, 
no specific therapy for this disease has been available 
up to now [1] 
Many therapies for PED have been 
suggested, such as: anti-iflammation, artificial tear, 
nutritious solution for ocular surface, soft contact lens, 
tarsorrhaphy, keratoplasty [1]. However, some PEDs 
were even failed to heal and the visual functions were 
threatened in spite of extensive treatments [2], [3], [4], 
[5]. Amniotic membrane transplantation has been 
recently employed in PED with promised result, 
nonetheless the success rate were varied in many 
studies (from 31.4% to 90%) [2], [6], [7]. Moverover, 
using amniotic graft may reduce the corneal 
transparent and visual acuity. Stem cell technologies 
have been applied to treat PEDs in some special 
situations, and supposed a new promised therapy for 
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this disease. Cultivated epithelial autografts (limbal 
stem cells, oral mucosal cells) or cultivated epithelial 
allografts (amniotic epithelial cells) have been tried in 
some rough cases with promised results [7], [8], [9], 
[10]. Parmar DN, et al., (2006) firstly successfully 
performed the trial of using tissue-cultured amniotic 
epithelial cells for 3 refractory PED cases [7]. 
Cord lining epithelial cells (CLECs) are 
epithelial cells of amniotic membrane of umbilical 
cord. These cells have been isolated and proved to be 
progenitor/stem cells. CLECs were differentiated to be 
some type of epithelium by some invitro study [11], 
[12], [13]. Zhou Y, MacAry PA, et al., have shown 
many markers of corneal and limbal epithelial cells in 
CLECs and the safety of CLECs human 
transplantation [12], [14]. Reza HM, (2011) has 
differentiated CLECs to corneal epithelial cells and 
transplanted them to rabbit eyes. The results showed 
that rabbits’ cornea after CLECs transplatation had no 
limbal stem cells deficiency signs and remained 
transparent with normal histology structures up to 10 
weeks postoperatively. These studies have suggested 
the CLECs application in treatment of ocular surface 
diseases, especially PEDs – one of the difficult treated 
corneal diseases [11]. From this hypothesis we 
carried out the prospective study to evaluate the 
efficacy of the transplantation of tissue-cultured 
CLECs in treatment of refractory PEDs. 
 
 
Materials and Methods 
 
Subjects  
In this study, 37 patients with PED in Vietnam 
National Institute of Ophthalmology were enrolled 
from December 2010 to May 2014. All patients were 
followed up at least 36 months. All our cases had 
been failed to healed with other treatment therapies. 
The descemetocele or perforated ulcer, corneal ulcer 
with inflammatory infitrative site or abscess in deep 
stroma, the PEDs with total limbal stem cells 
deficiency or the eyes with eyelid malformation were 
excluded from the study. 
This study was approved by the institutional 
review board of Vietnam National Institute of 
Ophthalmology, and informed consent was obtained 
from all patients. 
 
The tissue-cultured CLECs preparation 
The cells sheets were cultured in the 
laboratory of Department of surgery, National 
University of Singapore. The isolated CLECs were 
evaluated for the quality and expression of surface 
markers, and stored in single-cell suspension on 
culture dish with the density of 3-4 x 10
4
 cells/cm
2
 at -
196°C. Then, they were taken out of storage tanks 
and thawed at 37°C in water bath. And the cells were 
supplemented with PTTe-1 medium to the falcon 
tissue culture inserts (12-well plates) at density 
around 10000 cells/cm
2
. The next step, the culture 
plates were put straight into 37
o
C/5% CO2 incubator. 
The fresh culture media was replaced every 2 days 
until the cells grew into a continuous surface on the 
scaffold (from 5 to 7 days), consists of 1-2 cell layers. 
Finally, the cultured CLECs were determined the 
markers of cornea-like epithelial cells (CK3, CK12). 
For transportation, the Falcon tube (50ml) with 
cultured fluid contained 2 wells storage in -80°C. 
 
The tissue-cultured CLECs transplantation 
 The PEDs was cleaned by cresent knife to 
prepare transplantation site. The cells sheet with 
scaffold was cut to the shape and size of the ulcer. 
Then, the sheet was placed with the epithelium side 
down, and covered with soft contact lens. Two 
crossed Vicryl 8/0 sutures were placed over the 
contact lens to sclera for pressing and fixing the cells 
sheet. In necessary case, the combined surgeries 
such as hypopion lavage, pterygium excision and 
conjunctival autograft were done. Second cells 
transplantation was performed when the PEDs were 
ameliorated but not completely healed 4 weeks after 
the first surgery. The fixation sutures were removed to 
check the healing of the defect 7 days after surgery. 
Postoperative medications included topical 
moxifloxacin 0.5% (Vigamox; Alcon Laboratories, Inc. 
Fort Worth, USA) four times daily and sodium 
hyaluronate 0.1% (Sanlein, Santen Pharmaceutical 
Company) six times daily. 
The result of cells sheet transplantation was 
evaluated by two criteria; the time of healing and the 
quality of the corneal transplantation site. The 
treatment success meant the PED was completely 
healed after one or more transplatation, the failure 
meant the PED was not healed after transplatation or 
the corneal epithelial defect was recurrently appeared 
in 4 weeks after surgery and was not able to regraft. 
The quality of the transplantation site on 
cornea was clinical evaluated and catergorized into 3 
grades: good - the epithelial surface was smooth, the 
cornea was transparent and the anterior segment 
could be seen clearly. There is no neovessel at 
transplantation site; moderate-the epithelial surface 
was not smooth, but there is no epithelial defect. The 
cornea was mild opaque, but the pupil was able to 
see. There were neovessels in anterior stroma at 
transplantation site; bad-the epithelial surface was 
rough and there is epithelial defect or corneal 
recurrent erosion. The cornea was very opaque and 
the anterior segment could not be seen. There were 
many neovessles at at transplantation site, some of 
them were in posterior stroma. 
To detect any abnormal cells on transplatation 
site, the impression cytology was done 1 month, 3 
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months and 6 months postoperatively in success 
cases. To know whether CLECs were stayed at 
transplantation sites, as well as partially understand 
the epithelial healing mechanisms of defect, some 
male CLECs graft were used in female cornea. Then 
we performed keratoplasty for those cases to take the 
cornea for searching for CLECs. The SRY (the 
specific marker of Y chromosome) were tested in the 
cell-received cornea by PCR to determine the 
existence of CLECs on transplanation site by 
Genetics and Molecular biology laboratory of Vietnam 
Military Medical Universisty. 
 
 
Results  
 
The characteristics of studied patients and 
 PEDs before surgery 
There were 37 patients (26 male, 11 female) 
with the age from 21 to 86 years old (average 59.6 ± 
19.8 years old). All patients have unilateral corneal 
ulcer. 
The original causes of the corneal ulcers were 
described in Table 1. Most of the causes were 
infection (26/37 eyes) with 14 herpertic eyes (37.8%).  
Table 1: Original causes of the corneal ulcers 
Causes Quantity Percentage 
Infection Herpes 14 37.8 
Bacteria 11 29.7 
Fungi 1 2.7 
After surgery 3 8.1 
After radiation 1 27 
Eye trauma 2 5.4 
Sjogren syndrome 1 2.7 
Unidentified causes 4 10.9 
Total 37 100 
 
The period time of the corneal defects were 
from 4 weeks to 28 weeks (9.9 ± 5.2 weeks) and the 
period time of the PEDs were from 2 weeks to 13 
weeks (5.0 ± 2.9 weeks). All patients in our study 
were refractory with medical treatment (stopping 
corneal toxic eye drop, using artificial tear, using 
contact lens...). There were 2 recurent PEDs after 
AMT (Figure 1).  
 
Figure 1: The previous treatments of PEDs; (AMT: amniotic 
membrane transplantation; NSAIDs: non steroid anti-inflammation 
drugs).  
 
The size of the PEDs were from 11% to 65% 
corneal area (average 33.9 ± 14.9 % corneal area). 
The depth of PEDs were mostly less than two thirth of 
corneal thickness (33/37 eyes). The combined ocular 
lesions were shown in Figure 2. 
 
Figure 2: Combined ocular lesions; (MGD: meibomian gland 
dysfuntion). 
 
The results of tissue-cultured CLECs 
 transplantation 
The success rate of our study was 91.9% 
(34/37 eyes). There were 31 cases completely 
epithelialized in 2 weeks, 2 cases in 4 weeks, only 
one case with healing time more than 4 weeks and 
need second surgery. In 3 cases that failed to heal 
with transplantation, there was only one case recurred 
epithelial defect a week after healing. 
We found no association betweent healing 
time and some PEDs characteritics (original causes, 
the period time of the defects and the PED, the size of 
defect). Hoewever, the correlation between the time of 
epithelial healing and the tear secrection was 0,36 (p 
< 0,05). The healing time of eyes with the reduction of 
cornea sensation was longer than the healing time of 
the others (p < 0.05). The healing time of eyes that 
were both reduction of tear secrection and MGD (10.1 
± 5.5 days) were significant longer than the others 
(7.8 ± 4.1 days) (p < 0.05). 
Table 2: The quality of the transplantation sites 
Transplantation site 
Follow-up time 
Good Moderate Bad Total 
1 month (34 eyes) 12 19 3 34 
3 months (33 eyes) 20 11 2 33 
6 months (32 eyes) 25 7 0 32 
12 months (30 eyes) 25 5 0 30 
36 months (30 eyes) 24 5 1 30 
The last checked time (30 eyes) 26 4 1 30 
(At the end of the study, 30 eyes were followed up from 36 to 64 months, average 45 ± 7.7 
months, the others were done corneal transplant as the schedule). 
 
One eye recurred herpes keratitis at corneal 
transplantation site 17 months postoperatively. After 
successful treated, the corneal scar was hazy with 
stroma neovascularization, so the transplanation site 
was clasified as bad quality. 
The number of successful cases were done 
impression cytology at 1 month postoperatively was 
27 cases, at 3 months was 24 cases and 6 months 
was 31 cases (exception 3 keratoplasty eyes). The 
pictures of cytologies showed normal epithelial cells: 
cuboidal shape, quite uniform size, and round 
nucleus, the same as cells on normal cornea (Figure 
3B, and Figure 1D). There were no abnormal nucleus 
in these cells. Some cells at the bad transplantation 
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site were in grade of mild metaplasia (Figure 3F and 
3G). 
 
Figure 3: The corneal transplantation site and results of impression 
cytology; A) good transplantation site 3 months postoperatively; B) 
impression cytology of same patient (HE, x 100); C) moderate 
transplantation site 3 months postoperatively; D) impression 
cytology of same patient (HE, x 200); E) bad transplantation site 1 
month postoperatively; F) and G) impression cytology of same 
patient (HE, x 100 and x 400) 
 
In 4 corneal transplanted eyes, there were 3 
females, that were done keratoplasty in 1.5 months, 3 
months and 27 months postoperatively, and one male 
(6 months after surgery). The histology of corneal 
specimens showed normal epithelium at 
transplanation sites, but the number of layers 
increased (about 12-15 layers) (Figure 4). There were 
no inflammation cells infiltrated beneath the 
transplanation sites. The PCR test looking for SRY 
were negative in all 3 female cornea, but the test 
results of cells sheet and male conea were positive.  
 
Figure 4: The histology of cell-received cornea (Trichrome-Masson, 
x 100); A) healthy corneal epithelium with Bowman layer; B) the 
connection between the healthy cornea and transplantation site; C) 
the transplantation site without Bowman layer 
 
There were some mild complications in 
surgical procedure. Thirty eyes were subconjunctival 
haemorrhage without any interruption of surgical 
procedure. One eye was severe haemorrhage and the 
conjunctiva was inflated, so the contact lens had to 
been trephined to 10 mm in diameter to be easier to 
fixed.  
The postoperative complications were not 
severe. One contact lens was lost fixation 4 days 
postoperatively, then the cells sheet was removed and 
the contact lens was replaced until the cornea was 
completely healed (12 days after surgery). There were 
2 eyes that the cells sheets were slightly moved 
inspite of good fixation contact lens. After removing 
the fixation sutures, all these eye were completely 
epithelial healed.  
 
 
Discussion 
 
The mechanism of PEDs were partially 
specified by original causes of the corneal ulcer, the 
combined ocular lesions and the previous treatments. 
In our study, the original causes of two thirth eyes 
were infection (26/37 eyes, Table 1) , the remarkable 
combined ocular lesions were the reduction of cornea 
sensation, dry eye, hypopyon (Fig. 2), so that the two 
main mechanisms of PED in our patients might be 
ocular inflammation and neurotropic keratopathy. The 
addition mechanism was epithelial toxic from eye 
drops (Fig. 1). The other mechanisms may not be 
important role in our study group. 
Amniotics membrane was proven to inhibit 
inflammatoty reaction, scar creation, and neovascular 
growth, as well as promote epithelial migration, 
adhesion when overlay transplantation in PED [6], 
[15]. These bilogical efficacies were suggested from 
many mediator factors (such as EGF, KGF, and HGF, 
macrophage inhibitory factor, Fas ligand...) inside 
amniotic epithelial cells and somewhat in membrane 
stroma [16], [17]. For amniotic membrane graft, these 
factor may just existed on transplantation site for short 
time after surgery because of nonviable amniotic 
epithelial cells and dissovled stroma [15], [18]. So that 
viable amniotic cells may be supposed more effective 
in treating PED than amniotic membrane 
transplantation. Parma (2006) showed succesful 
corneal epithelial healing in 3 complicated PEDs that 
had been failed with other therapies. Although the 
healing mechanism of amniotic epithelial cells 
transplantation in his study remains unclear, the 
author presumed the trans-planted cells firstly may 
provide an initial cellular means to repair the PED and 
then promote epithelialization by in situ release of 
anti-inflammatory and healing factors in these cells 
[7]. Other mentioned mechanism was tissue-cultured 
cells may also provide a mechanical scaffold 
promoting subsequent epithelial healing of the cornea. 
In earlier experiments, He YG had transplanted 
human amniotic epithelial cells onto denuded rabbit 
corneal surfaces, these cells had been re-polarized 
and tightly adhered to the recipient corneal stroma 
24h after transplantation. However, the transplantation 
site was repopulated by host corneal epithelium after 
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10 days [19]. 
CLECs were amniotic epithelial cells around 
umbilical cord, so their microstructure was the same 
as amniotic cells. They were one kind of stem cell and 
were able to differentiated to corneal-liked epithelial 
cells [12], [13], [20]. Moreover, CLECs also were 
transplanted in rabbits' cornea with total limbal stem 
cell deficiency with good results. There were 50% 
cases had no limbal stem cells deficiency signs and 
the corneas remained transparent with normal 
histology structures up to 10 weeks postoperatively 
[11]. Therefore, transplantation tissue-cultured CLECs 
on PEDs may promote healing in the similar 
mechanisms of amniotic epithelial cells. In our study, 
we also found that CLECs were not able to exist long 
time on transplantation site after surgery. The PCR 
test for Y chromosome in female corneal specimens 
showed negative result as soon as 1.5 months 
postoperatively. Thus, it suggested that the donor 
CLECs improved the ocular surface through the 
secretion of factors promoting wound healing, 
stimulating repopulation of the remaining host corneal 
epithelial cells. It explained the high success rate in 
our studied group with most PEDs caused by 
inflammation and neurotrophic keratopathy. 
The most important influential factors of the 
CLECs transplantation is tear film. The correlations 
between the tear secrection, situation of MGD and the 
quality transplantation sites as well as healing time 
were statitistically significant (p < 0.05). The healing 
time were statitistically significant longer in the group 
of reduction of cornea sensation. These factors (tear 
film, cornea sensation) also contributed to PEDs 
mechanism, so the medical treatments to ameliorate 
them before and after CLECs transplantation were 
also played important role in the result of CLECs 
surgery. 
In our study, the cells sheet with scaffold was 
placed on the defect with the epithelium side down 
with the fixation of two Vicryl 8/0 sutures. This method 
showed the good result: 22/37 eyes complete healing 
after removing fixation sutures (a week 
postoperatively), 10 eyes more in 2 weeks 
postoperatively and 2 eyes healed in 3 weeks. Using 
directly scaffold of cells sheets instead of collagen 
shield with concave shape (in Parmar method [7]) 
made the cultivated procedure simplier and cheaper. 
However the cultured-well scaffold was flat so it was 
to difficult to force adherently 100% cells sheets on 
corneal surface, especilally when the defect was 
larger than 50% corneal area. Our method to fix the 
tissue sheet with 2 cross sutures press on soft contact 
lens is quite easy and simple with good effect. 
Although these sutures on sclera easily created 
subconjunctival haemorrhage that made difficult to fix 
contact lens. We usually used vasoconstriction eye 
drops to prevent this complication (adrenaline 0.1%). 
In conclusion, tissued-cultured human cord 
lining epithelial cells transplantation is a safe and 
effective treatment of persistent corneal epithelial 
defect. This transplantation open a new method in 
treatment of this complicated diseased. However, 
more studies with long follow up time were need to re-
evaluate the efficacy as well as the mechanism of 
corneal healing of this cells tranplantation. 
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